Pharmacy Transparency Compared: Providers That Name Their Compounder

When you order compounded semaglutide or tirzepatide, do you know which pharmacy is making your medication? In most cases, no. The majority of GLP-1 telehealth providers don't disclose which compounding pharmacy fills their prescriptions. This is a transparency gap that matters more than most patients realize.

Why Compounder Identity Matters

Not all compounding pharmacies are equal. The quality spectrum ranges from PCAB-accredited 503B outsourcing facilities with pharmaceutical-grade testing to small 503A pharmacies with minimal oversight. The difference affects:

• Sterility: How clean is the production environment? Contaminated compounded medications have caused serious infections and deaths in the past.
• Potency accuracy: Is the dose on the label actually in the vial? Under-potent medication means suboptimal treatment. Over-potent medication means heightened side effects.
• Testing protocols: Does the pharmacy perform beyond-use-date testing, endotoxin testing, and potency verification on each batch?
• Regulatory compliance: Has the pharmacy received FDA warning letters, state board actions, or had products recalled?

The Transparency Spectrum

The 503A vs. 503B Distinction

503A pharmacies compound individual patient prescriptions under state pharmacy board oversight. They're not required to register with the FDA, follow FDA cGMP (current Good Manufacturing Practices), or report adverse events to the FDA. Quality varies significantly.

503B outsourcing facilities compound larger batches and are registered with the FDA, inspected by the FDA, and subject to cGMP requirements. They offer a higher baseline of manufacturing quality and regulatory oversight.

Knowing whether your medication comes from a 503A or 503B facility tells you a lot about the manufacturing standards behind it. A provider that uses 503B facilities has chosen a higher-cost, higher-quality supply chain.

What "LegitScript Certified" Actually Means

LegitScript is a third-party certification body that evaluates healthcare merchants for legitimacy, regulatory compliance, and operating standards. A LegitScript certification means the provider has been vetted against standards including: proper licensing, adherence to advertising regulations, appropriate prescribing practices, and use of licensed pharmacies.

GobyMeds prominently displays their LegitScript certification. This doesn't guarantee perfect outcomes, but it does indicate a provider that has voluntarily submitted to external oversight — a meaningful trust signal in a market where many providers operate with minimal third-party accountability.

The Brand-Name Alternative

Sesame Care eliminates the compounding transparency question entirely by offering only FDA-approved brand-name medications (Wegovy, Zepbound, Rybelsus). You know exactly what you're getting because it's manufactured by Novo Nordisk or Eli Lilly in FDA-inspected facilities. The tradeoff is price — brand-name medications cost more — but you're paying for manufacturing certainty.

Questions Every Patient Should Ask

1. Which compounding pharmacy fills my prescription?
2. Is it a 503A or 503B facility?
3. Does the pharmacy hold PCAB accreditation?
4. Does the pharmacy perform potency and sterility testing on each batch?
5. Has the pharmacy received any FDA warning letters or state board actions?

If a provider can't or won't answer these questions, consider whether that level of opacity is acceptable for a medication you'll inject into your body weekly.

The Bottom Line

Pharmacy transparency is a proxy for quality commitment. Providers that disclose their pharmacy partners are demonstrating confidence in their supply chain. Providers that don't may have good pharmacies — but they're not giving you the information to verify that for yourself.